Valuation : Edwards Lifesciences Corporation

Market Cap 52B 44.81B 42.01B 38.35B 72.24B 4,970B 72.47B 498B 194B 2,509B 195B 191B 8,318B P/E 2026 *
35.6x
P/E 2027 * 27.3x
Enterprise Value 48.37B 41.68B 39.08B 35.67B 67.2B 4,623B 67.41B 464B 181B 2,333B 182B 178B 7,737B EV / Sales 2026 *
7.16x
EV / Sales 2027 * 6.3x
Free-Float
86.96%
Yield 2026 *
-
Yield 2027 * -
1 day+0.29%
1 week+0.47%
Current month+4.81%
1 month+7.80%
3 months+4.94%
6 months+4.33%
Current year+5.82%
1 week 89.46
Extreme 89.46
92.12
1 month 85.05
Extreme 85.05
93.91
Current year 74.66
Extreme 74.66
96.29
1 year 72.3
Extreme 72.3
96.29
3 years 58.93
Extreme 58.93
96.29
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 2023-05-10
Director of Finance/CFO 43 2026-05-28
Chief Tech/Sci/R&D Officer 51 2025-08-31
Director TitleAgeSince
Chairman 69 2024-05-06
Director/Board Member 62 2015-02-09
Director/Board Member 58 2023-05-10
Date Insider Type Main position Quantity % Market Cap.
8/26/26 Sell

Executive/Senior Manager

-1,240 0.0002%
8/26/26 Fiscal year

Executive/Senior Manager

95,400 0.0166%
8/11/26 Fiscal year

Executive/Senior Manager

1,857 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+0.29%+0.47%+11.06%+18.65% 52B
-1.35%-1.13%+27.04%+14.12% 230B
+0.18%-1.27%+5.25%-17.37% 152B
+1.51%-1.64%-21.37%+23.59% 132B
+0.36%-7.01%-55.71%-12.92% 67.88B
+0.66%-1.69%-16.57%-13.62% 51.05B
-2.44%-3.25%+23.11%+28.29% 43.38B
-1.56%+0.97%+39.32%+47.34% 40.74B
-5.31%-1.74%+117.39%+36.28% 32.55B
+1.94%+3.81%-12.73%+48.46% 34.67B
Average -0.59%-0.93%+11.68%+17.28% 83.58B
Weighted average by Cap. -0.36%-1.31%+7.34%+10.92%

Financials

2026 *2027 *
Net sales 6.76B 5.82B 5.46B 4.99B 9.39B 646B 9.42B 64.79B 25.28B 326B 25.38B 24.83B 1,081B 7.43B 6.4B 6B 5.48B 10.32B 710B 10.35B 71.21B 27.78B 358B 27.89B 27.29B 1,188B
Net income 1.44B 1.24B 1.16B 1.06B 1.99B 137B 2B 13.76B 5.37B 69.24B 5.39B 5.27B 230B 1.9B 1.63B 1.53B 1.4B 2.64B 181B 2.64B 18.18B 7.09B 91.51B 7.12B 6.97B 303B
Net Debt -3.63B -3.13B -2.93B -2.68B -5.04B -347B -5.06B -34.8B -13.58B -175B -13.63B -13.34B -581B -5.19B -4.48B -4.2B -3.83B -7.22B -496B -7.24B -49.79B -19.43B -251B -19.5B -19.08B -831B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
26-08-28 $90.21 +0.29% 2,043,696
26-08-27 $89.95 -0.91% 3,059,265
26-08-26 $90.78 -0.10% 2,778,784
26-08-25 $90.87 +0.41% 2,389,753
26-08-24 $90.50 +0.79% 2,722,012
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
90.21USD
Average target price
100.96USD
Spread / Average Target
+11.92%

Quarterly revenue - Rate of surprise